XOMA Royalty (XOMA) Competitors $26.00 -0.42 (-1.57%) As of 11:11 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock XOMA vs. XOMAO, INVA, MNKD, NVAX, OPK, GERN, ZBIO, RIGL, LXRX, and MYGNShould you be buying XOMA Royalty stock or one of its competitors? The main competitors of XOMA Royalty include XOMA (XOMAO), Innoviva (INVA), MannKind (MNKD), Novavax (NVAX), OPKO Health (OPK), Geron (GERN), Zenas BioPharma (ZBIO), Rigel Pharmaceuticals (RIGL), Lexicon Pharmaceuticals (LXRX), and Myriad Genetics (MYGN). These companies are all part of the "medical" sector. XOMA Royalty vs. Its Competitors XOMA Innoviva MannKind Novavax OPKO Health Geron Zenas BioPharma Rigel Pharmaceuticals Lexicon Pharmaceuticals Myriad Genetics XOMA Royalty (NASDAQ:XOMA) and XOMA (NASDAQ:XOMAO) are both medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their earnings, profitability, dividends, valuation, media sentiment, analyst recommendations, institutional ownership and risk. Do institutionals & insiders have more ownership in XOMA or XOMAO? 95.9% of XOMA Royalty shares are owned by institutional investors. 9.1% of XOMA Royalty shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term. Does the media favor XOMA or XOMAO? In the previous week, XOMA Royalty had 8 more articles in the media than XOMA. MarketBeat recorded 14 mentions for XOMA Royalty and 6 mentions for XOMA. XOMA Royalty's average media sentiment score of 0.15 beat XOMA's score of -0.31 indicating that XOMA Royalty is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment XOMA Royalty 2 Very Positive mention(s) 0 Positive mention(s) 9 Neutral mention(s) 3 Negative mention(s) 0 Very Negative mention(s) Neutral XOMA 1 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 2 Very Negative mention(s) Neutral Is XOMA or XOMAO more profitable? XOMA has a net margin of 0.00% compared to XOMA Royalty's net margin of -13.04%. XOMA's return on equity of 0.00% beat XOMA Royalty's return on equity.Company Net Margins Return on Equity Return on Assets XOMA Royalty-13.04% -12.43% -4.85% XOMA N/A N/A N/A Do analysts recommend XOMA or XOMAO? XOMA Royalty currently has a consensus target price of $69.50, indicating a potential upside of 167.26%. Given XOMA Royalty's stronger consensus rating and higher possible upside, equities research analysts clearly believe XOMA Royalty is more favorable than XOMA.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score XOMA Royalty 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00XOMA 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Which has preferable earnings & valuation, XOMA or XOMAO? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioXOMA Royalty$13.05M23.85-$13.82M-$1.15-22.61XOMA$13.05MN/AN/AN/AN/A SummaryXOMA Royalty beats XOMA on 7 of the 10 factors compared between the two stocks. Get XOMA Royalty News Delivered to You Automatically Sign up to receive the latest news and ratings for XOMA and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding XOMA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart XOMA vs. The Competition Export to ExcelMetricXOMA RoyaltyMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$311.50M$2.98B$5.44B$9.65BDividend YieldN/A2.46%3.99%4.14%P/E Ratio-22.6318.0530.0425.06Price / Sales23.85175.18373.4277.08Price / CashN/A41.8335.9458.58Price / Book3.747.218.125.67Net Income-$13.82M-$54.43M$3.25B$265.39M7 Day Performance4.99%0.07%0.96%2.54%1 Month Performance-1.72%5.29%2.69%1.89%1 Year Performance11.37%9.94%28.08%24.09% XOMA Royalty Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)XOMAXOMA Royalty4.3001 of 5 stars$26.01-1.6%$69.50+167.3%+11.9%$311.50M$13.05M-22.6310Upcoming EarningsXOMAOXOMAN/A$25.34+0.3%N/A-0.8%$0.00$13.05M0.0010Upcoming EarningsINVAInnoviva4.3056 of 5 stars$18.59-0.2%$40.33+117.0%+1.8%$1.17B$358.71M-18.41100Positive NewsEarnings ReportAnalyst RevisionMNKDMannKind3.4273 of 5 stars$3.92+4.5%$9.86+151.5%-31.5%$1.14B$285.50M39.20400Earnings ReportAnalyst ForecastAnalyst RevisionNVAXNovavax4.7101 of 5 stars$6.75+2.9%$15.86+134.9%-18.0%$1.06B$682.16M2.551,990News CoverageEarnings ReportOPKOPKO Health4.1309 of 5 stars$1.27+6.7%$2.75+116.5%-3.9%$943.73M$713.10M-5.082,997News CoverageAnalyst RevisionGERNGeron3.1376 of 5 stars$1.21+3.4%$4.61+281.1%-71.5%$745.19M$76.99M-5.76229Earnings ReportAnalyst RevisionGap UpZBIOZenas BioPharma1.6935 of 5 stars$16.81+9.1%$36.67+118.1%N/A$644.66M$5M-4.74N/ARIGLRigel Pharmaceuticals3.3254 of 5 stars$22.67+3.5%$36.40+60.6%+208.4%$391.58M$179.28M10.95160Trending NewsEarnings ReportAnalyst ForecastAnalyst RevisionHigh Trading VolumeLXRXLexicon Pharmaceuticals3.0701 of 5 stars$1.12+4.7%$3.67+227.4%-28.2%$386.80M$31.08M-2.20140News CoverageAnalyst ForecastMYGNMyriad Genetics3.6199 of 5 stars$3.98+1.8%$14.38+261.4%-77.1%$360.41M$837.60M-3.552,700 Related Companies and Tools Related Companies XOMA Alternatives Innoviva Alternatives MannKind Alternatives Novavax Alternatives OPKO Health Alternatives Geron Alternatives Zenas BioPharma Alternatives Rigel Pharmaceuticals Alternatives Lexicon Pharmaceuticals Alternatives Myriad Genetics Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:XOMA) was last updated on 8/8/2025 by MarketBeat.com Staff From Our PartnersAltucher: Trump’s Great Gain is startingNew Hampshire just launched a Strategic Crypto Reserve — and James Altucher says it’s the first sign that “Tru...Paradigm Press | SponsoredBREAKING: The House just passed 3 pro-crypto bills!THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. Crypto 101 Media | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | SponsoredCritical AI announcement set to ignite AI 2.0 A new 100% tariff on imported chips just rattled the tech sector—sending some stocks soaring and others tumbli...Timothy Sykes | SponsoredTrump’s new nightmareAccording to Porter Stansberry and Jeff Brown, a government-led financial mobilization is already reshaping Am...Porter & Company | SponsoredWhat Steve Bannon revealed about Trump’s gold playA Trump advisor just said 3 words that could reset the dollar. It’s a gold move nobody saw coming—and your ...Reagan Gold Group | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding XOMA Royalty Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share XOMA Royalty With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
